Localized Prostate Cancer clinical trials

Explore recruiting localized prostate cancer clinical trials.

Recruiting localized prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Localized Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Ultra-hypofractionated radiotHErapy and concomitant oral RelugOlix for treatment of intermediate risk prostate cancer. (Ultra-HERO)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

EvaluatioN of High-Intensity Focused Ultrasound (HIFU) Hemi-ablation and short-term AndrogeN deprivation therapy Combination to Enhance prostate control for intermediate risk localized prostate cancer: the ENHANCE prospective feasibility trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

PEACE2 : A randomized Phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse

Belgium, France, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Translational research study to discover molecular changes in patients with localized prostate cancer undergoing robotic-assisted radical prostatectomy and treated for 4 weeks with Enzalutamide compared to those not treated with Enzalutamide

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Open-label clinical phase 1/2 study to assess the safety and efficacy of the SpectraCure P18 System and verteporfin for injection for the treatment of primary localized prostate cancer

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

PEACE 7 : A randomized Phase III trial with a factorial design evaluating the efficacy and safety of darolutamide and stereotactic dose escalated radiotherapy in patients with localized prostate cancer and high-risk features ofrelapse, from the Prostate Cancer Consortium in Europe (PEACE).

France, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Localized Prostate Cancer trials by city

Localized Prostate Cancer in Toronto Localized Prostate Cancer in Vancouver Localized Prostate Cancer in Montreal Localized Prostate Cancer in Calgary Localized Prostate Cancer in Edmonton Localized Prostate Cancer in Ottawa Localized Prostate Cancer in Winnipeg Localized Prostate Cancer in Quebec City Localized Prostate Cancer in Hamilton Localized Prostate Cancer in Kitchener Localized Prostate Cancer in London Localized Prostate Cancer in Halifax Localized Prostate Cancer in New York Localized Prostate Cancer in Los Angeles Localized Prostate Cancer in Chicago Localized Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease